Production of GLP-1 drugs like Ozempic and Wegovy continues to power the Danish economy—since late 2021, Danish GDP growth has been 3.6%, but it would have been 0% without the contribution of rapid pharmaceutical manufacturing growth - ThreadSky

josephpolitano.bsky.social • 104 days ago

Production of GLP-1 drugs like Ozempic and Wegovy continues to power the Danish economy—since late 2021, Danish GDP growth has been 3.6%, but it would have been 0% without the contribution of rapid pharmaceutical manufacturing growth

Comments

friendotoday.bsky.social•104 days ago

I would shit a brick if I was Danish - whole economy growing on a few products….

michde.bsky.social•100 days ago

now , hear me out... if they got into snacks too, boom, circular profit

glassbro.bsky.social•104 days ago

-30% without licorice and healthcare for licorice-bourne illnesses.

mikko-puhakka.bsky.social•103 days ago

A jackpot for Denmark. It seems.

chiliconkarma.bsky.social•104 days ago

Novo 2019 stockholder meeting had a vote on loving the profit taken from insulin. 99%+ of the votes were against. https://www.novonordisk.com/content/dam/nncorp/global/en/about-us/pdfs/corporate-governance/annual-general-meetings/agm2019/uk/minutes-voting-results-agm-2019.pdf

greenhombre.bsky.social•104 days ago

If the USA had socialized medicine and could negotiate prices with big pharma, would Danish profits on these drugs have been so high?

andrewmceo.bsky.social•104 days ago

What happens when they go off patent or is that not an issue?

sleepyfkndev.bsky.social•103 days ago

its a huge problem. NN is investing in alternatives but so far cagril doesnt look very stable in trials. tirzepatide/retatrutide and eli lilly are going to solidly run away with the market soon. the only saving grace is that "ozempic" has brand value with the casuals.

andrewmceo.bsky.social•103 days ago

Interesting.